
|Videos|January 22, 2019 (Updated: December 19, 2020)
Perioperative Immunotherapy the Future of HCC Treatment?
Author(s)Ahmed Kaseb, MD
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Advertisement
Cancer Network spoke with Dr. Ahmed Kaseb about a phase II pilot trial of perioperative immunotherapy for resectable HCC and how the results could change future perioperative treatment of the disease.
Newsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.
Advertisement
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Grants Tentative Approval to PNT2003 for GEP-NETs
2
CHMP Recommends Pembrolizumab Regimen for Approval in Pretreated PROC
3
Evaluating Thyroid Cancer Risk After GLP-1 Receptor Agonist Administration
4
What Were The Key Prostate Cancer Abstracts at ASCO GU 2026?
5




















































